{
  "ticker": "JAT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02974473",
  "id": "02974473",
  "pages": 8,
  "price_sensitive": true,
  "date": "20250730",
  "time": "1102",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250730/pdf/06m9rqpb97k8zv.pdf",
  "summary": "### **Material Information Summary**  \n\n#### **Quarterly Report (Appendix 4C)**  \n- **Revenue from ongoing operations:** $11.5m (Q4 FY25), up **76% QoQ**.  \n- **Gross profit:** $3.8m, up **31% QoQ**.  \n- **Net operating cash flow:** $0.65m, up **101% QoQ**.  \n- **Closing cash balance:** **$3.114m** (vs. $2.385m previous quarter).  \n- **Moroka\u00ae sales (China 618 Festival):** Record GMV of **RMB10.0m ($2.1m) in May, RMB8.6m ($1.8m) in June** (150% YoY growth).  \n- **HS incentive partnership sales:** Exceeded **$8m in FY25** (vs. $3.4m FY24); target **$11m+ for FY26**.  \n- **ANMA facility updates:** New OEM clients onboarded; automation upgrades (laser barcode printer, sachet machine).  \n- **FY25 guidance:** Unaudited net loss after tax **$7.6m\u2013$8.0m** (unchanged).  \n\n#### **Key Operational Updates**  \n- **Product development:** 6 new Moroka\u00ae SKUs launched (e.g., Children\u2019s Growth, Immunity Knight).  \n- **Neurio\u00ae stock sales:** Cleared via domestic channels after China trademark dispute.  \n\n**No capital raising, trading halt, or other material corporate actions identified.**  \n\n*(Omitted: Non-material operational details, director commentary, and administrative updates.)*",
  "usage": {
    "prompt_tokens": 4638,
    "completion_tokens": 355,
    "total_tokens": 4993,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-30T01:50:05.667997"
}